New Delhi, April 10 The two new tuberculosis vaccines could be safe for use in adults and children in India, but may not provide protection against all forms of the infectious bacterial disease, according to phase-3 trial results published in The British Medical Journal.Phase-3, a randomized...
bcg vaccine
cadila pharmaceuticals
clinical trial
extrapulmonary tuberculosis
householdcontactstudy
icmr
immuvac
indian council of medical research
latent tuberculosis infection
prevention of tuberculosis
serum life science europe gmbh
tb incidence
tuberculosis vaccine
vaccine efficacy
vpm1002